Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Archaimbault SA"'
Autor:
Kim BK; Department of Ophthalmology Discovery, Pharmaceutical Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland.; Institute of Chemical Sciences and Engineering (ISIC), École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland., Goncharov T; Department of Immunology Discovery, Genentech, 1 DNA Way, South San Francisco, CA, USA., Archaimbault SA; Department of Ophthalmology Discovery, Pharmaceutical Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland., Roudnicky F; Therapeutic Modalities, Pharmaceutical Research and Early Development, F. Hoffmann-La Roche Ltd, Basel, Switzerland., Webster JD; Department of Pathology, Genentech, 1 DNA Way, South San Francisco, CA, USA., Westenskow PD; Department of Ophthalmology Discovery, Pharmaceutical Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland., Vucic D; Department of Immunology Discovery, Genentech, 1 DNA Way, South San Francisco, CA, USA. domagoj@gene.com.
Publikováno v:
Cell death and differentiation [Cell Death Differ] 2024 Oct 24. Date of Electronic Publication: 2024 Oct 24.
Autor:
Avramovic D; Ocular Technologies, Immunology, Infectious Diseases and Ophthalmology, Pharmaceutical Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., 4070 Basel, Switzerland., Archaimbault SA; Ocular Technologies, Immunology, Infectious Diseases and Ophthalmology, Pharmaceutical Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., 4070 Basel, Switzerland., Kemble AM; Neuroscience and Rare Disease, Pharmaceutical Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., 4070 Basel, Switzerland., Gruener S; Ocular Technologies, Immunology, Infectious Diseases and Ophthalmology, Pharmaceutical Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., 4070 Basel, Switzerland., Lazendic M; Ocular Technologies, Immunology, Infectious Diseases and Ophthalmology, Pharmaceutical Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., 4070 Basel, Switzerland., Westenskow PD; Ocular Technologies, Immunology, Infectious Diseases and Ophthalmology, Pharmaceutical Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., 4070 Basel, Switzerland.
Publikováno v:
Biomedicines [Biomedicines] 2022 Jun 14; Vol. 10 (6). Date of Electronic Publication: 2022 Jun 14.